US HB6609 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 36-0)
Status: Introduced on April 23 2020 - 25% progression, died in committee
Action: 2020-04-23 - Referred to the House Committee on Financial Services.
Pending: House Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 23 2020 - 25% progression, died in committee
Action: 2020-04-23 - Referred to the House Committee on Financial Services.
Pending: House Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the President, within 24 hours of this bill's enactment, to issue purchase orders for a program of the highest national urgency (commonly known as a DX purchase order) to procure under the Defense Production Act of 1950 (DPA) supplies to conduct COVID-19 (i.e., coronavirus disease 2019) medical testing nationwide. The supplies must have received prior approval from the Centers for Disease Control and Prevention or have received emergency use authorization from the Food and Drug Administration for the detection of COVID-19. The bill waives certain DPA requirements relating to industrial resource and critical technology shortfalls and notification to Congress.
Title
Immediate COVID Testing Procurement Act.
Sponsors
Rep. Jimmy Panetta [D-CA] | Rep. Anthony Brown [D-MD] | Rep. Judy Chu [D-CA] | Rep. Gil Cisneros [D-CA] |
Rep. Peter DeFazio [D-OR] | Rep. Adriano Espaillat [D-NY] | Rep. Tulsi Gabbard [D-HI] | Rep. Raul Grijalva [D-AZ] |
Rep. Alcee Hastings [D-FL] | Rep. Jared Huffman [D-CA] | Rep. Derek Kilmer [D-WA] | Rep. David Loebsack [D-IA] |
Rep. Tom Malinowski [D-NJ] | Rep. Sean Maloney [D-NY] | Rep. Grace Meng [D-NY] | Rep. Jerrold Nadler [D-NY] |
Rep. Grace Napolitano [D-CA] | Rep. Eleanor Norton [D-DC] | Rep. Donald Payne [D-NJ] | Rep. Dean Phillips [D-MN] |
Rep. Kathleen Rice [D-NY] | Rep. C.A. Ruppersberger [D-MD] | Rep. Bobby Rush [D-IL] | Rep. Bradley Schneider [D-IL] |
Rep. Terri Sewell [D-AL] | Rep. Albio Sires [D-NJ] | Rep. Abigail Spanberger [D-VA] | Rep. Thomas Suozzi [D-NY] |
Rep. Filemon Vela [D-TX] | Rep. Cedric Richmond [D-LA] | Rep. James McGovern [D-MA] | Rep. TJ Cox [D-CA] |
Rep. Don Beyer [D-VA] | Rep. Elaine Luria [D-VA] | Rep. Mark Pocan [D-WI] | Rep. Val Demings [D-FL] |
History
Date | Chamber | Action |
---|---|---|
2020-04-23 | House | Referred to the House Committee on Financial Services. |
2020-04-23 | House | Introduced in House |
Subjects
Cardiovascular and respiratory health
Congressional oversight
Defense spending
Emergency medical services and trauma care
Government operations and politics
Health technology, devices, supplies
Infectious and parasitic diseases
Medical tests and diagnostic methods
Military procurement, research, weapons development
Presidents and presidential powers, Vice Presidents
Public contracts and procurement
War and emergency powers
Congressional oversight
Defense spending
Emergency medical services and trauma care
Government operations and politics
Health technology, devices, supplies
Infectious and parasitic diseases
Medical tests and diagnostic methods
Military procurement, research, weapons development
Presidents and presidential powers, Vice Presidents
Public contracts and procurement
War and emergency powers
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/6609/all-info |
Text | https://www.congress.gov/116/bills/hr6609/BILLS-116hr6609ih.pdf |